| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accuracy of dwell position detection with a combined electromagnetic tracking brachytherapy system for treatment verification in pelvic brachytherapy
|
van Heerden, Laura
|
|
|
154 |
C |
p. 249-254
|
article
|
| 2 |
Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study
|
Joseph, Kurian
|
|
|
154 |
C |
p. 93-100
|
article
|
| 3 |
A macroscopic salivary gland and a potential organ or simply tubarial sero-mucinous glands?
|
Narayan, Ravi K.
|
|
|
154 |
C |
p. 324-325
|
article
|
| 4 |
Are “tubarial salivary glands” a previously unknown structure?
|
Mudry, Albert
|
|
|
154 |
C |
p. 314-315
|
article
|
| 5 |
Author’s response to letter to the editor regarding JHAM Kaanders et al. “Advances in cancer imaging require renewed radiotherapy dose and target volume concepts”
|
Kaanders, Johannes H.A.M.
|
|
|
154 |
C |
p. e9
|
article
|
| 6 |
Can radiation-recall predict long lasting response to immune checkpoint inhibitors?
|
Deutsch, Eric
|
|
|
154 |
C |
p. 125-127
|
article
|
| 7 |
Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan
|
Demizu, Yusuke
|
|
|
154 |
C |
p. 1-5
|
article
|
| 8 |
Challenges influencing the utilization of prostate brachytherapy in the United States
|
Odei, Bismarck
|
|
|
154 |
C |
p. 123-124
|
article
|
| 9 |
Clinical implementation of 3D in vivo dosimetry for abdominal and pelvic stereotactic treatments
|
Esposito, Marco
|
|
|
154 |
C |
p. 14-20
|
article
|
| 10 |
Clinical implementation of pencil beam scanning proton therapy for liver cancer with forced deep expiration breath hold
|
Fracchiolla, Francesco
|
|
|
154 |
C |
p. 137-144
|
article
|
| 11 |
Clinical implications of tubarial salivary glands
|
Thakar, Alok
|
|
|
154 |
C |
p. 319-320
|
article
|
| 12 |
Comment on a systematic review and meta-analysis on single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis
|
Bravo, Isabel
|
|
|
154 |
C |
p. e1
|
article
|
| 13 |
Comment on professional quality of life and burnout amongst radiation oncologists: The impact of alexithymia and empathy
|
Leung, John
|
|
|
154 |
C |
p. e22
|
article
|
| 14 |
Comments on “The tubarial salivary glands: First description of a potential new organ at risk for head-neck radiotherapy”
|
Cohen Goldemberg, Daniel
|
|
|
154 |
C |
p. 316-317
|
article
|
| 15 |
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma
|
Hu, Yihuai
|
|
|
154 |
C |
p. 6-13
|
article
|
| 16 |
Contents
|
|
|
|
154 |
C |
p. iii-vi
|
article
|
| 17 |
Corrigendum to “Interaction between CIEDs and modern radiotherapy techniques: Flattening filter free-VMAT, dose-rate effects, scatter radiation, and neutron-generating energies” [Radiother Oncol 152 (2020) 196–202]
|
Gauter-Fleckenstein, Benjamin
|
|
|
154 |
C |
p. 291
|
article
|
| 18 |
Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation
|
Rühle, Alexander
|
|
|
154 |
C |
p. 276-282
|
article
|
| 19 |
Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
|
Levin-Epstein, Rebecca G.
|
|
|
154 |
C |
p. 207-213
|
article
|
| 20 |
Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer
|
Song, Jiheon
|
|
|
154 |
C |
p. 101-109
|
article
|
| 21 |
Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group
|
García-Consuegra, Alejandro
|
|
|
154 |
C |
p. 128-134
|
article
|
| 22 |
Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac
|
Winkel, Dennis
|
|
|
154 |
C |
p. 243-248
|
article
|
| 23 |
Editorial Board
|
|
|
|
154 |
C |
p. ii
|
article
|
| 24 |
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|
Concin, Nicole
|
|
|
154 |
C |
p. 327-353
|
article
|
| 25 |
Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis
|
Mendez, Lucas C.
|
|
|
154 |
C |
p. 118-122
|
article
|
| 26 |
ESTRO ACROP guidelines for target volume definition in pancreatic cancer
|
Brunner, Thomas B.
|
|
|
154 |
C |
p. 60-69
|
article
|
| 27 |
Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting
|
Wagenaar, Dirk
|
|
|
154 |
C |
p. 45-52
|
article
|
| 28 |
High-throughput meta-analysis and validation of differentially expressed genes as potential biomarkers of ionizing radiation-response
|
Biolatti, Vanesa
|
|
|
154 |
C |
p. 21-28
|
article
|
| 29 |
Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
|
Iqbal, Muhammad Shahid
|
|
|
154 |
C |
p. e13
|
article
|
| 30 |
Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases
|
Werensteijn-Honingh, Anita M.
|
|
|
154 |
C |
p. 110-117
|
article
|
| 31 |
Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic
|
Murakami, Naoya
|
|
|
154 |
C |
p. 274-275
|
article
|
| 32 |
In response to Haas RL et al.
|
Roeder, F.
|
|
|
154 |
C |
p. 306-307
|
article
|
| 33 |
In response to: “Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT task force/ACROP recommendations”
|
Haas, R.L.
|
|
|
154 |
C |
p. 170-171
|
article
|
| 34 |
In response to Leung
|
Franco, Pierfrancesco
|
|
|
154 |
C |
p. e23-e24
|
article
|
| 35 |
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling
|
Zheng, Shuhua
|
|
|
154 |
C |
p. 36-44
|
article
|
| 36 |
Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer
|
Gort, Elske M.
|
|
|
154 |
C |
p. 194-200
|
article
|
| 37 |
Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription
|
Yan, Di
|
|
|
154 |
C |
p. 235-242
|
article
|
| 38 |
Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer
|
Bartkowiak, Detlef
|
|
|
154 |
C |
p. 255-259
|
article
|
| 39 |
Letter to the editor concerning Offersen et al., [Radiother Oncol 2015; 114: 3–10]
|
Stouthandel, Michael E.J.
|
|
|
154 |
C |
p. 135-136
|
article
|
| 40 |
Letter to the editor concerning Valstar et al., [Radiother Oncol 2020 Sep 23;S0167-8140(20)30809-4. doi: 10.1016/j.radonc.2020.09.034]
|
Bikker, Floris J.
|
|
|
154 |
C |
p. 318
|
article
|
| 41 |
Letter to the editor regarding Lee J, Shin IS, Yoon WS, Koom WS, Rim CH. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review. Radiother Oncol 2020;145:63–70
|
Johnston, Edward W.
|
|
|
154 |
C |
p. e4-e5
|
article
|
| 42 |
Letter to the editor regarding the article “Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma” by Fei et al.
|
Rim, Chai Hong
|
|
|
154 |
C |
p. e18-e19
|
article
|
| 43 |
Letter to the Editor regarding “The tubarial salivary glands: A potential new organ at risk for radiotherapy”
|
Nascimento, José J.C.
|
|
|
154 |
C |
p. 323
|
article
|
| 44 |
No convincing evidence for the presence of tubarial salivary glands: A letter to the editor regarding “The tubarial salivary glands: A potential new organ at risk for radiotherapy”
|
Iwanaga, Joe
|
|
|
154 |
C |
p. 321-322
|
article
|
| 45 |
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach
|
Hosni, Ali
|
|
|
154 |
C |
p. 70-75
|
article
|
| 46 |
NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer
|
Huang, Huakang
|
|
|
154 |
C |
p. 87-92
|
article
|
| 47 |
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience
|
Intven, M.P.W.
|
|
|
154 |
C |
p. 172-178
|
article
|
| 48 |
Patient-reported outcome measures (PROMs) in routine care palliative radiotherapy
|
Schuler, Thilo
|
|
|
154 |
C |
p. e10-e11
|
article
|
| 49 |
Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality
|
Batumalai, V.
|
|
|
154 |
C |
p. 299-305
|
article
|
| 50 |
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
|
Biau, J.
|
|
|
154 |
C |
p. 227-234
|
article
|
| 51 |
Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03
|
Choi, Kyu Hye
|
|
|
154 |
C |
p. 179-186
|
article
|
| 52 |
Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy
|
Via, Riccardo
|
|
|
154 |
C |
p. 53-59
|
article
|
| 53 |
Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study
|
Lin, Chia-Hsin
|
|
|
154 |
C |
p. 76-86
|
article
|
| 54 |
Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer
|
Cui, Yanfen
|
|
|
154 |
C |
p. 161-169
|
article
|
| 55 |
Proton therapy for selected low grade glioma patients in the Netherlands
|
van der Weide, Hiska L.
|
|
|
154 |
C |
p. 283-290
|
article
|
| 56 |
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes
|
Xie, Xiaoxue
|
|
|
154 |
C |
p. 187-193
|
article
|
| 57 |
Radiation oncology in the new virtual and digital era
|
Aznar, Marianne C.
|
|
|
154 |
C |
p. A1-A4
|
article
|
| 58 |
Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer
|
Li, Jie
|
|
|
154 |
C |
p. 201-206
|
article
|
| 59 |
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results
|
Hoskin, Peter J.
|
|
|
154 |
C |
p. 214-219
|
article
|
| 60 |
Rate of radiation-induced microbleed formation on 7T MRI relates to cognitive impairment in young patients treated with radiation therapy for a brain tumor
|
Morrison, Melanie A.
|
|
|
154 |
C |
p. 145-153
|
article
|
| 61 |
Regarding Kaanders JHAM et al. “Advances in cancer imaging require renewed radiotherapy dose and target volume concepts”
|
Liang, Shinn-Jye
|
|
|
154 |
C |
p. e8
|
article
|
| 62 |
Response to Chai’ letter: What caused the difference in prognosis among different physicians?
|
Qiu, Xiufang
|
|
|
154 |
C |
p. e20-e21
|
article
|
| 63 |
Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
|
Kepka, Lucyna
|
|
|
154 |
C |
p. e14
|
article
|
| 64 |
Response to Letter to the Editor by Johnston and Fotiadis regarding “Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.”
|
Rim, Chai Hong
|
|
|
154 |
C |
p. e6-e7
|
article
|
| 65 |
Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”
|
Tchelebi, Leila T.
|
|
|
154 |
C |
p. e17
|
article
|
| 66 |
Response to SAFFRON spinal radiosurgery comments
|
Singh, Raj
|
|
|
154 |
C |
p. e2-e3
|
article
|
| 67 |
Response to Schuler et al. patient-reported outcome measures (PROMs) in palliative radiotherapy
|
Oldenburger, Eva
|
|
|
154 |
C |
p. e12
|
article
|
| 68 |
RE: Valstar et al., “The tubarial salivary glands: A potential new organ at risk for radiotherapy”
|
Ellsworth, Susannah G.
|
|
|
154 |
C |
p. 312-313
|
article
|
| 69 |
Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond
|
Cellini, Francesco
|
|
|
154 |
C |
p. e15-e16
|
article
|
| 70 |
Role of radiotherapy in the management of brain metastases of NSCLC – Decision criteria in clinical routine
|
Glatzer, Markus
|
|
|
154 |
C |
p. 269-273
|
article
|
| 71 |
Salivary glands at the pharyngeal ostium of the Eustachian tube are already described in histological literature
|
Schumann, Sven
|
|
|
154 |
C |
p. 326
|
article
|
| 72 |
Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases
|
Dupic, Guillaume
|
|
|
154 |
C |
p. 260-268
|
article
|
| 73 |
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost
|
Alayed, Yasir
|
|
|
154 |
C |
p. 29-35
|
article
|
| 74 |
The radiotherapy utilization rate in pediatric tumors: An analysis of 13,305 patients
|
Bishr, Mai K.
|
|
|
154 |
C |
p. 220-226
|
article
|
| 75 |
The tubarial glands paper: A starting point. A reply to comments
|
Valstar, Matthijs H.
|
|
|
154 |
C |
p. 308-311
|
article
|
| 76 |
The tubarial salivary glands: A potential new organ at risk for radiotherapy
|
Valstar, Matthijs H.
|
|
|
154 |
C |
p. 292-298
|
article
|
| 77 |
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials
|
Gambacorta, Maria Antonietta
|
|
|
154 |
C |
p. 154-160
|
article
|
Journal description